Streetbeat News

Partnerships

BA

LUV

Southwest Airlines (NYSE:LUV) shares dropped in premarket trading after the company revised its Q1 2024 guidance downwards, citing lower-than-expected leisure passenger volumes and a reduction in Boeing (NYSE:BA) 737 MAX aircraft deliveries. The revised forecast includes flat to 2% RASM growth, a decrease in expected aircraft deliveries from 79 to 46, and an increase in CASM-X by approximately 6%. Additionally, Southwest anticipates a Q1 net loss but expects profitability in March. The company also plans to reduce its workforce by the end of the year.

Portfolio Pulse from Nabaparna Bhattacharya

March 12, 2024 | 1:29 pm

AAL

At the JPM Conference, the CEO of American Airlines highlighted that aircraft manufacturers have been unable to deliver on schedule, impacting the airline's operations.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:27 pm

APO

PARA

Apollo Global Management has approached Paramount Global with a proposal for a potential deal. The specifics of the deal, including whether it involves a full acquisition, partnership, or another form of collaboration, have not been disclosed. This move by Apollo indicates a strategic interest in the media and entertainment sector, potentially aiming to leverage Paramount's extensive content library and distribution networks.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:19 pm

KSS

During a conference call, a Kohl's executive reported that in Q4, sales at Sephora locations within Kohl's stores increased by over 70%, and comparable sales growth was nearly 25%. Additionally, the partnership with Sephora will be expanded in 2024, with plans to open about 140 smaller-format shops.

Portfolio Pulse from Charles Gross

March 12, 2024 | 1:16 pm

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX), also known as MangoRx, announced the launch of 'PRIME' by MangoRx, an FDA-approved oral testosterone replacement therapy (TRT). This product aims to target men currently on TRT or experiencing low testosterone symptoms, leveraging MangoRx's telehealth platform for distribution. The company plans to market PRIME to a significant addressable market, including those averse to injectable TRT, by utilizing social media influencers, celebrities, and athletes. PRIME's launch represents a strategic expansion into a new vertical with substantial market potential.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:09 pm

LIQT

LiqTech International, Inc. (NASDAQ:LIQT) has received its first U.S.-based oil & gas produced water order from Razorback Direct Oilfield Solutions and Services LLC, marking a significant milestone in its North American expansion. The order is for a containerized pilot system for produced water treatment, leveraging LiqTech's silicon carbide ceramic membranes technology. This follows a distribution agreement between LiqTech and Razorback Direct aimed at commercializing LiqTech's filtration technology for water treatment in the U.S. oil & gas sector. The successful operation of a similar system in the Middle East, demonstrating high efficiency and minimal chemical use, supports the potential for this technology in the U.S. market.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:08 pm

GLASF

GRAM

LEEEF

Benzinga's Elliot Lane discussed the California cannabis industry's challenges and opportunities on The Water Tower Hour podcast, highlighting insights from Benzinga's event in Los Angeles. Key topics included market navigation, operational excellence, and brand innovation with insights from Leef Brands, Glass House Brands, and Gold Flora Co. The discussion also previewed the upcoming Cannabis Capital Conference in Florida.

Portfolio Pulse from Patricio Liddle

March 12, 2024 | 1:08 pm

HPE

Hewlett Packard Enterprise (HPE) is reportedly considering Foxconn as a potential partner for a significant AI server order, according to DigiTimes. This move could indicate HPE's intention to expand its presence in the AI server market, leveraging Foxconn's manufacturing capabilities.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:05 pm

BTCY

Biotricity Inc. (NASDAQ:BTCY) announced the expansion of its Cardiac AI Cloud platform, leveraging advancements in AI to improve operational efficiency and margins. The company is developing a cardiac AI clinical model to support clinical decisions, with plans to file for FDA clearance by year-end. The healthcare AI market is expected to reach $208.2 billion by 2030, with remote patient monitoring anticipated to hit $96.67 billion. Biotricity's expansion includes partnerships with Google's TensorFlow and Amazon Web Services, aiming to enhance diagnostic accuracy and patient outcomes through predictive analytics and the analysis of over 500 billion heartbeats.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:04 pm

BA

UAL

United Airlines Holdings' CEO announced plans to convert to Max 10s pending certification. This move indicates a strategic shift towards newer, potentially more efficient aircraft models.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 1:03 pm